BioNTech Will Price Vaccine Below Market Rates

BioNTech is planning to price the two-shot regimen of the COVID-19 vaccine below “typical market rates” and would even differentiate pricing between regions or nations. The company is currently first in the race to disclose interim information from a large-scale trial showing a highly effective COVID-19 vaccine.

Read more

Qatar Signs Agreement to Buy Moderna Vaccine

Qatar has signed a deal with drugmaker Moderna to buy its potential COVID-19 vaccine once it is finally approved and released for global use. While there are no internationally approved vaccines yet, several are in advanced trials, including from Pfizer, Johnson & Johnson and Moderna.

Read more

Purdue will Plead Guilty over Opioid Practices

OxyContin maker Purdue Pharma agreed to plead guilty to criminal charges over its handling of its prescription opioid OxyContin on Wednesday afternoon, in a deal with United States prosecutors that sidestepped paying billions of dollars in penalties and stopped short of criminally charging the Sackler family owners.

Read more